Conformis Inc represents strong values and a clear corporate philosophy. As a leading medical technology company, Conformis focuses on providing customized orthopedic implants, designed to fit each patient's unique anatomy. Commitment to innovation, patient-centricity, and improving the quality of life drive Conformis' operations. By leveraging advanced imaging technology and proprietary software, the company aims to streamline the surgical process, enhance patient outcomes, and reduce healthcare costs. Conformis' unwavering dedication to personalized solutions and delivering exceptional patient experiences solidifies its position as a trusted leader in the orthopedic industry.

Conformis Inc is primarily present in the United States.

Conformis Inc, a leading medical technology company, has achieved several significant milestones. The company has successfully developed and commercialized innovative joint replacement implants and systems that are tailored to each patient's unique anatomy. Conformis Inc has received FDA clearance for its knee and hip replacement products, showcasing their commitment to safety and effectiveness. They have also gained regulatory approvals in various markets around the world, expanding their global presence. Additionally, Conformis Inc has secured partnerships and collaborations with renowned orthopedic organizations, enabling them to advance their research and development efforts. This dedication to innovation and strategic partnerships has positioned Conformis Inc as a leader in the orthopedic medical device industry.

Conformis Inc, founded in 2004, is a leading medical technology company that specializes in orthopedic implant design and manufacturing. The company is headquartered in Billerica, Massachusetts. Conformis Inc focuses on providing patient-specific and highly customized joint replacement solutions, particularly knee and hip implants. By utilizing advanced 3D printing technology and imaging software, Conformis Inc is able to create implants that are tailored to each patient's unique anatomy, resulting in potentially better outcomes and improved patient satisfaction. The company has a successful track record of innovation and is committed to addressing the individual needs of patients while ensuring the highest quality of care.

Conformis Inc faces competition from various players in the orthopedic implant market. Some of its main competitors include Zimmer Biomet Holdings Inc, Stryker Corporation, and Smith & Nephew plc. These companies also specialize in manufacturing and marketing orthopedic implants, including knee and hip replacements. Conformis Inc distinguishes itself by offering patient-specific implants and instrumentation, providing a personalized approach to orthopedic surgery. Despite competition, Conformis Inc has carved a niche for itself with its innovative solutions tailored to individual patients, enhancing the overall quality of care in the orthopedic industry.

Conformis Inc is primarily active in the medical devices industry.

The business model of Conformis Inc is focused on providing innovative and patient-specific solutions for orthopedic surgeons. The company develops and sells personalized joint replacement implants and associated surgical instruments. Through advanced imaging technology and proprietary software, Conformis Inc creates implants that are tailor-made for each patient, taking into account their unique anatomy. By offering this personalized approach, Conformis Inc aims to enhance patient outcomes, improve surgical efficiency, and reduce the need for secondary surgeries. This patient-specific solution sets Conformis Inc apart and positions the company as a leader in the field of orthopedic joint replacements.

Коефициентът на цена спрямо печалбата (КЦП) на Conformis е -0,02.

Коефициентът на цена към оборот (KUV) на Conformis е 0,27.

AlleAktien качественият резултат за Conformis е 3/10.

очаквана Conformis оборотът е 60,12 млн. USD.

очаквана Conformis печалба е -887,25 млн. USD.

Conformis Inc. is a leading company in the field of medical technology that develops, manufactures, and sells specially customized orthopedic implants and instruments for use in knee, hip, and shoulder surgery. The company combines state-of-the-art technology with clinical insights to provide unique solutions for individual anatomical needs and surgical challenges. The business model is based on the production and sale of personalized implants and instruments, using computer-assisted imaging technologies and manufacturing processes to produce individualized implants and instruments in series. This allows for a precise fit and faster healing, leading to better outcomes for patients. The company is active in three main segments: knee, hip, and shoulder. In knee surgery, Conformis offers a portfolio of knee implants that are made according to the specific needs of the patient, including total, partial, cartilage, and ligament-replacing implants. In hip surgery, Conformis offers a customized acetabular cup that helps ensure a precise fit and more natural hip movements. The company also offers customized hip implants that meet the anatomical needs of the patient. In shoulder surgery, Conformis offers a wide range of individualized shoulder implants, including total and partial implants. The implants are particularly precise with regard to the rotator cuff, the size and shape of the joint head, as well as the acromion and glenoid. Conformis is also proud to offer instruments and accessories that allow surgeons to receive real-time interactive information about the patient's anatomy during the procedure. These include patient-specific templates and drill templates that accurately match the patient's anatomical requirements. Another important pillar of the business model is collaboration with clinicians and surgeons. Conformis works with renowned clinics and surgeons to constantly develop and improve new products. The company aims to reduce procedural errors and increase the efficiency of orthopedic surgery. Overall, the business model of Conformis Inc. is focused on providing personalized solutions in orthopedic surgery that help patients heal faster and better. The company focuses on product development, manufacturing, distribution, and collaboration with doctors and clinics to ensure that the patient's need for individualized solutions is optimally met. Conformis Inc. is an innovative company with a strong focus on improving patient care.

Conformis разпределя дивидента от 0 USD на плащания годишно.

Дивидентата за Conformis в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на Conformis е US20717E1010.

WKN на Conformis е A14T0Y.

Тикерът на Conformis е CFMS.

През последните 12 месеца Conformis изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква Conformis да изплати дивиденда в размер на 0 USD.

Дивидентната доходност на Conformis в момента е .

Conformis изплаща дивидент на тримесечие. Той се разпределя в месеците .

Conformis платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 USD. Това съответства на дивидентна доходност от 0 %.

Conformis се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от Conformis на 10.09.2024 г. в размер на 0 USD, трябваше да притежавате акцията в портфейла си преди Ex-деня на 10.09.2024 г..

Последното дивидентно плащане беше извършено на 10.09.2024 г..

През година 2023 Conformis изплати 0 USD под формата на дивиденти.

Дивидентите от Conformis се изплащат в USD.